Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway

BACKGROUND: Exploring the underlying mechanism of rituximab resistance is critical to improve the outcomes of patients with diffuse large B-cell lymphoma (DLBCL). Here, we tried to identify the effects of the axon guidance factor semaphorin-3F (SEMA3F) on rituximab resistance as well as its therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiong, Ma, Naya, Li, Xinlei, Yang, Chao, Zhang, Wei, Xiong, Jingkang, Zhu, Lidan, Li, Jiali, Wen, Qin, Gao, Lei, Yang, Cheng, Rao, Lingyi, Gao, Li, Zhang, Xi, Rao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278727/
https://www.ncbi.nlm.nih.gov/pubmed/37114652
http://dx.doi.org/10.1097/CM9.0000000000002686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278727/
https://www.ncbi.nlm.nih.gov/pubmed/37114652
http://dx.doi.org/10.1097/CM9.0000000000002686

Ejemplares similares